Monitoring symptoms in patients undergoing hemodialysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SMaRRT-HD trial is a cluster randomized trial that evaluates the effectiveness of a symptom monitoring system in hemodialysis patients compared to usual care. Approximately 2400 patients from 30 diverse hemodialysis clinics across the US will participate. The trial utilizes an electronic patient-reported outcome measure (ePROM) system to regularly assess symptoms and facilitate clinician follow-up, aiming to reduce unrecognized symptoms and improve communication between patients and care teams. Clinics assigned to the SMaRRT-HD group will implement this system for a duration of 12 months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Treatment with hemodialysis at a participating dialysis clinic
* English or Spanish speaking

Exclusion Criteria:

* Not willing to report their symptoms using the SMaRRT-HD platform
* Not willing to share clinically acquired data with the research team
* Underlying condition such as dementia that is anticipated to prevent comprehension of the trial information document (fact sheet)
* Incarceration

Where it's running

• Fresenius Medical Care
  Waltham, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Jennifer Flythe, MD — University of North Carolina, Chapel Hill

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Staged kidney implantation with hypothermic oxygenated machine perfusion during combined heart and kidney transplants

  This trial will test whether keeping the donor kidney on oxygenated machine perfusion and implanting it later helps adults who are receiving both a heart and a kidney transplant.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT06877169

• Moda-flx Hemodialysis System for clinic and at-home use

  This trial will test whether the Moda-flx Hemodialysis System can be used safely and effectively by trained professionals in clinics and by trained patients and care partners at home for adults with end-stage kidney disease.

  Recruiting at 5 sites Diality Inc. · San Dimas, California and 4 other locations · NCT06613568

• Inserting peritoneal dialysis catheters using a bedside technique

  This study is testing a new way to insert peritoneal dialysis catheters at the bedside for patients who can't have general anesthesia, to see if it can help more people access this treatment.

  Recruiting at 2 sites Universitair Ziekenhuis Brussel · Brussels and 1 other locations · NCT06065982

• Comparing two beta blockers for heart health in dialysis patients

  This study is testing which beta blocker, metoprolol or carvedilol, is better for heart health in veterans on dialysis to see if it can help them live longer and feel better.

  Recruiting at 12 sites Phase 3 VA Office of Research and Development · Long Beach, California and 17 other locations · NCT05931276

• Comparing Incremental Hemodialysis to Conventional Hemodialysis

  This study is testing if a new way of doing hemodialysis called incremental hemodialysis can help people with end-stage kidney disease feel better and have fewer hospital visits compared to the standard method.

  Recruiting at 10 sites Wake Forest University Health Sciences · Jacksonville, Florida and 9 other locations · NCT05828823

• Investigating the safety and mechanisms of SGLT2 inhibitors in patients on peritoneal dialysis

  This study is testing if a diabetes medication called empagliflozin is safe and helpful for people on peritoneal dialysis who still have some kidney function, to see if it can protect their heart and kidneys.

  Recruiting Phase 3 University Health Network, Toronto · Toronto, Ontario · NCT05715814

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.